DONATE

IBEC Seminar: Dr. Ubaka Ogbogu

Foregrounding justice, equity and inclusion as determinants of access to precision medicine: an ethical case study of patient-derived tissue organoids. Dr. Ubaka Ogbogu, Professor and the Associate Dean Research in … Read more

Researchers design a microfluidics device to predict cancer therapy response

One of the great challenges in the fight against cancer is to design new technologies for a personalized treatment for each patient. Depending on the molecular characteristics —DNA mutations for instance— of each tumour, precision medicine aims to make it easier for cancer patients, both adult and paediatric, to receive a personalized treatment that is appropriate to their pathology. But is it possible to know whether or not a patient can benefit from a treatment before starting therapy?